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SUMMARY
The aim of this study was to quantify the impact of radiologic image review performed 
by experienced radiologists in a multidisciplinary team (MDT) for head and neck cancers 
(HNCs). We performed a retrospective review of cases discussed at MDT meetings from 
April 2014 to March 2017 for which radiologic review was required. All changes in the for-
mer radiologic report were collected and classified as follows: 1) modifications of radiolog-
ical reports (patients for whom the treatment strategy had not been defined at the moment 
of MDT meeting) and 2) modifications in treatment strategy (patients for whom treatment 
strategy had previously been defined and subsequently modified according to the outcome 
of radiologic revision). The latter subgroup was further categorised as “major changes” and 
as “minor changes”. A total of 540 cases were retrieved. Imaging review was required at the 
time of tumour diagnosis in 310 (57.4%) cases. Most patients (69%) had advanced stage tu-
mours (III and IV). In 262 (48%) cases, no change of the initial radiologic report was made. 
In a total of 144 (27%) cases, the available imaging was not considered sufficient for a final 
indication to treatment and further imaging was required. In the remaining 134 (25%) cases, 
radiologic review led to a modification of either tumour staging (55%) or treatment strategy 
(45%). Specifically, major and minor modifications were applied in 44 (13%) and 17 (11%) 
of the cases considered, respectively. Among 134 patients for whom the radiologic review 
led to stage/treatment modification, follow-up was available for 118. In all but one patient, 
we could confirm the original reports were correctly modified per MDT discussion results. 
Our data strongly support the importance of including an experienced radiologist as a core 
member of the MDT for HNCs.
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RIASSUNTO
Scopo del lavoro è stato quello di quantificare l’impatto della revisione radiologica condot-
ta da radiologi esperti nell’ambito di un gruppo di lavoro multidisciplinare nella gestio-
ne dei tumori del distretto testa collo. È stata condotta un’analisi retrospettiva dei casi 
discussi nelle riunioni multidisciplinari svoltesi tra i mesi di aprile 2014 e marzo 2017, 
per i quali è stata richiesta una revisione radiologica. Le modifiche apportate ai referti 
radiologici originari sono state classificate come segue: 1) variazioni dello stadio tumorale 
e 2) cambiamenti alla strategia terapeutica, di seguito classificati come “rilevanti” e come 
“non rilevanti”. La revisione radiologica si è resa necessaria in 540 casi, in 310 (57,4%) 
si trattava di pazienti in prima diagnosi. La maggior parte dei pazienti (69%) presentava 
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Introduction
Head and neck cancers (HNCs) are a heterogeneous group 
of malignancies, which may arise in multiple subsites of 
an anatomically complex region. Despite the fact that na-
tional and international guidelines have led to a progres-
sive standardisation of indications for treatment, the avail-
ability of different equipment and expertise (e.g. transoral 
robotic surgery) may vary between single institutions, thus 
influencing treatment strategies. Moreover, as multimodal-
ity treatments have become the standard of care in locally 
advanced-stage disease, integrated management between 
different medical specialties has become paramount 1,2.
Multidisciplinary care has been shown to bring several ad-
vantages to patient management, including but not limited 
to shorter diagnosis-treatment time, greater adherence to 
clinical guidelines and optimisation of diagnostic and treat-
ment procedures 3-5. Arguably, the combined effect of these 
factors may account for the better oncological outcomes of 
patients managed by multidisciplinary teams (MDTs) com-
pared to those treated by a single referring physician  6-9. 
These data have encouraged the incorporation of multi-
disciplinary management into national and international 
guidelines on treatment of HNCs 10,11.
In agreement with this statement, in 2000 our institution 
established an ongoing MDT program to coordinate the 
different phases of HN patient management ranging from 
diagnosis to supportive care. MDT meetings are arranged 
according to a weekly schedule and involve radiation on-
cologists, radiologists, ear-nose-throat (ENT) surgeons 
and medical oncologists with well-recognised clinical and 
scientific expertise in the field. Additional professionals 
have gradually entered the core of the MDT, including pa-
thologists, dental surgeons, endocrinologists, speech thera-
pists and dieticians. Due to the increasing availability of 
both morphological and functional imaging in HN patient 
workup  12-14, the role of the radiologist has become para-
mount in every step of the clinical pathway.
Starting from these observations, the aim of the present 
study is to quantify the impact of inserting a radiologic im-
age review into the pattern of care of HNC patients and 
to verify whether such an imaging-based indication was 
adequately tailored based on the analysis of subsequent 
follow-up.
Materials and methods
At our institution, radiologists with specific expertise in 
HNC have become steady core members of the MDT start-
ing from 2010. Routinely, imaging may be reviewed both 
in the diagnostic setting and follow-up period for patients 
eligible either for surgical or a non-surgical approach. In 
the diagnostic setting, imaging reviews are performed to: 
1) discriminate between benign and malignant lesions, 2) to 
refine tumour staging, and 3) to define the optimal treat-
ment strategy, especially where radiological and clinical 
findings conflict. Conversely, if imaging review is required 
during the course of follow-up, the radiologist may be re-
quired to address at least one diagnostic issue from among 
the following: 1) disease persistence after a non-surgical 
strategy; 2) loco-regional recurrence and/or distant met-
astatic progression; 3) second primary tumour of the HN 
region; 4) surgical and/or radiotherapy sequelae (including 
osteoradionecrosis). Imaging review may be required either 
for examinations performed at our institution (if evaluated 
by a non-dedicated HN radiologist) or as a referral/second 
opinion for patients treated in other centres (with radiolog-
ic images evaluated by general radiologists). In those lat-
ter cases, reports from outside hospitals were available in 
the majority of cases. Whenever radiologic image review 
is required, both clinical information and DICOM (Digital 
Imaging and COmmunications in Medicine) files (CT and/
or MR) are provided to the radiologist at least one day be-
fore the MDT discussion for primary assessment. For the 
aim of the current analysis, we retrospectively reviewed 
all cases discussed at MDT meetings from April 2014 to 
March 2017. Of those, we selected only cases for whom a 
radiologic review of CT and/or MR was performed by two 
experienced radiologists. 
The radiologists involved in the image review process were 
LP and CG. Although there are no precise criteria to define 
radiologist “expertise” on evaluating radiologic images of 
tumori in stadio avanzato (III e IV). In 262 casi (48%) non è stato apportato alcun cambiamento rispetto alla valutazione radiologica iniziale. 
In 144 casi (27%), le immagini disponibili non sono state considerate sufficienti per una adeguata pianificazione terapeutica e sono state ri-
chieste ulteriori indagini diagnostiche. Nei rimanenti 134 casi (25%), la revisione radiologica ha portato a modificare lo stadio della malattia 
(55%) o la strategia terapeutica (44%). In particolare, variazioni “rilevanti” e “non rilevanti” alla strategia terapeutica sono state applicate 
rispettivamente in 44 (13%) e in 17 (11%) dei casi considerati. In 118 di tali pazienti erano disponibili i successivi controlli nel tempo. In tutti i 
casi, tranne uno, è stato possibile confermare che la modifica apportata ai referti originari in sede di discussione multidisciplinare era corretta. 
I nostri dati confermano l’importanza di includere un radiologo esperto come componente fondamentale dei gruppi di lavoro multidisciplinari 
per la gestione dei tumori del distretto testa-collo.
PAROLE CHIAVI: neoplasie laringologiche, gestione multidisciplinare, diagnostica per immagini, radiologia
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head and neck cancers, different parameters are generally 
considered: years of work on the topic, number of radiologic 
images examined, availability of modern radiologic equip-
ment, the expertise of the centre (high volume centres), 
availability of certification endorsed by scientific societies 
and involvement in multidisciplinary discussions. LP has 
15 years’experience in executing and reporting CT and MR 
HN examinations. Moreover, in 2013 he acquired the sub-
specialisation in Head and Neck Radiology endorsed by the 
European Society of Radiology. This qualification attests 
a standard of in-depth knowledge in the field of head and 
neck radiology. CG has 5 years’ experience in executing 
and reporting CT and MR HN examinations. During the 
period considered, their referral Department was the De-
partment of Diagnostic Imaging of the European Institute 
of Oncology which performs about 2600 HN radiologic 
exams per year including approximately 220 MRs per year, 
150 CTs per year and 2300 ultrasounds per year. LP and 
CG followed about 80% of the HN TC and MR exams of 
the Department. Both radiologists were fully involved in 
the MDT discussion of all cases requiring radiologic im-
ages revision. The study investigators were independent of 
the MDT radiologists. 
Inclusion criteria were as follows: 1) clinical and/or ra-
diological suspicion or histologically-proven diagnosis 
of HNC; 2) availability of a written medical record of the 
MDT discussion and final radiological report; 3) follow-up 
length of at least 12 months; 4) willingness and ability to 
sign a written informed consent for the use of personal da-
ta for educational and scientific purposes. Both malignant 
and benign tumour cases were included. Only CT and MR 
imaging were considered; data on positron emission to-
mography (PET) were also collected. Patients who were 
discussed regarding adjuvant treatment (i.e. radiation treat-
ment alone or in association with systemic treatment) and/
or diagnosis of thyroid cancers were excluded. 
The aim of the study was to quantify the impact of radio-
logic image review performed during MDT weekly dis-
cussion. Therefore, for each case, the original radiological 
report was compared to the result from the imaging re-
viewing process. The following descriptors were consid-
ered: 1) any changes in radiological reports in patients for 
whom treatment strategy had not been previously defined 
(Tumour Node Metastasis (TNM) staging system 7th ed. in 
cases of staging modification); 2) any changes in treatment 
strategy. The latter were categorised as either “major modi-
fications” (i.e. MDT non-indication to surgery in favour of 
radiotherapy ± systemic therapy, and vice versa) or “minor 
modifications” (i.e. MDT indication to an alternative ap-
proach: open versus than minimally-invasive surgery, and 
Figure 1. Consolidated Standards for Reporting Trials (CONSORT) diagram. 
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vice versa). Additionally, MDT final decision and accuracy 
of MDT indication-to-treatment (as evaluated by histologi-
cal confirmation and/or follow-up data) were collected. 
Patient- and disease-related characteristics were retrieved 
from electronic medical records. DICOM files were retro-
spectively reviewed for verification of complex cases (LP, 
CG). 
Descriptive statistical analysis was performed with the 
SAS statistical software (version 9.2; SAS Institute Inc, 
Cary, NC).
Results
A total of 2445 cases were discussed during the institu-
tional MDT meetings over the period considered. Radio-
logic imaging review was required in 649 (26%) cases; of 
those, 540 met inclusion criteria for the current analysis 
and constituted the final patient cohort. Details of case se-
lection are provided by the CONSORT diagram depicted in 
Figure 1. Patients were predominantly male (66%), median 
age was 63 (interquartile range, IQR: 52.9-71.6) years. The 
most represented HN subsite was the oropharynx (28%), 
followed by the larynx (19%) and oral cavity (18%). Fur-
ther patient demographics and disease-related details are 
provided in Table I. 
Imaging review was required at the time of tumour diag-
nosis in 310 (57.4%) cases. Most patients (69%) had ad-
vanced stage (III and IV) tumours. The remaining 230 
(42.6%) patients were discussed during the course of fol-
low-up, mainly because of suspected loco-regional recur-
rence (131 cases, 57%). Among all cases discussed, 124 
(23%) represented the second opinion of patients referred 
from another centres. Specifics on the setting of imaging 
review are summarised in Table II. 
Considering imaging modality, CT and MR were almost 
equally represented in our cohort, with 234 (43%) and 249 
(46%) of cases, respectively, as illustrated in Table III. Pa-
tient stratification according to MDT decision following 
radiologic imaging review is summarised in Figure 2. 
Details of the miscellaneous group (patients for whom radi-
ologic revision did not lead to any amendment in treatment 
strategy) are as follows: 
• Patients with prior indication to surgery for whom the 
TNM staging modification did not translate into a modi-
fication of the treatment strategy (56 patients 77%). 
The accuracy of staging modification could be verified 
through the pathological report, which confirmed ad-
equacy in all cases. 
• Patients for whom the diagnostic question was to dif-
ferentiate between benign and malignant lesions (11 pa-
tients, 14%). Of these, 6 patients (59%) underwent fur-
ther assessment through fine needle aspiration or biopsy, 
while 3 patients (25%) received an indication for clinical 
and/or radiological follow-up. For these 9 patients, mod-
ification of the radiologic report proved to be correct in 
all cases. As the remaining 2 patients (16%) were lost to 
follow-up, it was not possible to verify the appropriate-
ness of the radiologic report modification.
• Patients for whom the diagnostic question was to dif-
ferentiate between recurrent/persistent disease and treat-
ment-related sequelae (i.e. local recurrence vs post-RT 
osteoradionecrosis) (6 patients, 9%). Pathological con-
firmation was required in 4 cases, and the modification 
Table I. Patient and disease characteristics.
Number of patients 
(%)
Total number of patients 540
Gender
M 358 (66)
F 182 (34)
Age (at the time of multidisciplinary discussion)
Mean (range) year 61.8 (20-90)
Median (IQR) year 63.0 (52.9-71.6)
Head and Neck sites
Oral cavity 98 (18)
Oropharynx 152 (28)
Hypopharynx 24 (4)
Larynx 100 (19)
Salivary glands 60 (11)
Skin 17 (3)
Nasal cavity and paranasal sinuses 16 (3)
Lymph node metastasis from unknown primary 12 (2)
Recurrences of nasopharyngeal tumours 5 (1)
Other head and neck sites 56 (11)
Histology
Squamous cell carcinoma 391 (72)
Adenocarcinoma 15 (3)
Adenoid cystic carcinoma 23 (4)
Pleomorphic adenoma 17 (3)
Mucoepidermoid tumours 6 (1)
Sarcoma 9 (2)
Schwannoma 2 (0.5)
Paraganglioma 2 (0.5)
Neuroendocrine tumours 3 (0.6)
Benign histology 9 (2)
Other histology 17 (3)
N.A. at the time of discussion 46 (9)
CUP: cancer of the unknown primary; HNC: head and neck cancer; IQR: interquartile 
range; N.A.: not available; SCC: squamous cell carcinoma.
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of the initial radiologic report was proven to be accurate 
in all but one case (the detailed description of this case is 
provided later in the section). Of the remaining 2 cases, 
modification of the radiologic report was confirmed by 
subsequent imaging in one case, while the other case 
could not be verified as the patient was lost to follow-up. 
Missing follow-up data represented 21% (13/61) for pa-
tients for whom radiologic image revision led to a modifi-
cation in treatment strategy.
Overall, considering the whole cohort of 540 patients, im-
aging review led to modification of radiologic reports (mis-
cellaneous group) or in treatment strategy in 73 (13%) and 
61 (11%) of cases, respectively. 
Follow-up was available for 118 (86%) of the 134 patients 
for whom the radiological report was edited following the 
MDT meeting. Forty-five (37%) patients were submitted 
to subsequent surgery or cytohistologic sampling (specifi-
cally, 50% underwent surgical specimen examination, 35% 
were biopsied and 15% received a fine-needle biopsy). For 
the remaining 73 patients, the adequacy of radiologic indi-
cation was verified through further imaging and/or clinical 
examination during the follow up period.
Finally, among patients with available follow up (134 cases) in 
117 (87%) we could confirm that modification of the original 
reports as defined during the MDT discussion was correct. 
In only one case was the modification of initial radiologi-
cal chart not confirmed by subsequent histologic specimen 
examination. This was the case of a 70-year-old man with a 
diagnosis of early stage (cT2cN0M0) glottic cancer treated 
with curative radiotherapy followed by laser surgery for 
persistent disease. One year after the end of radiotherapy, 
a CT scan showed a partially necrotic tissue in the right 
residual larynx with transglottic extension. The finding was 
considered to be radiologically stable compared with two 
previous exams and was therefore considered as a radia-
tion-related sequela. Nevertheless, because of worsening 
symptoms and clinical evidence of cricoid cartilage expo-
Table II. Aim of the radiologic image revision, sorted by first-diagnosis and follow-up settings.
Setting of radiologic revision Number of patients (%)
Diagnosis 310 (57.4) 
Malignant tumours: early-stage disease 59 (19)
Malignant tumours: advanced-stage disease 216 (70)
Benign tumours 35 (11)
Follow-up 230 (42.6)
Suspected persistent disease 23 (10)
Suspected loco-regional recurrence 130 (57)
Suspected distant metastasis 19 (8)
Suspected loco-regional recurrence and distant metastasis 12 (5)
Suspected second primary tumour 28 (12)
Suspected surgical or radiation-sequelae (including osteoradionecrosis) 8 (3)
Surgical- or radiation sequelae versus locoregional recurrence 3 (2)
Other 7 (3)
Table III. Type of images reviewed by the multidisciplinary team.
Imaging modality No. of patients (%)
CT 234 (43)
MR 249 (46)
CT+MR 25 (4.5)
CT+PET 14 (3)
MR+PET 15 (3)
CT+MR+PET 3 (0.5)
CT: computed tomography; MR: magnetic resonance; PET: positron emission tomography
Figure 2. Schematic representation of cases stratification according to MDT 
decisions (tumour staging and indication-to-treatment).
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sure, after a second MDT discussion, the patient was indi-
cated for a total laryngectomy. The laryngectomy specimen 
revealed the presence of persistent malignancy. 
The management of cases presented for radiological review 
is depicted in Figure 3. In particular, available imaging could 
be deemed inadequate and/or insufficient for appropriate 
evaluation either due to technical issues (such as low-qual-
ity image) or to the need for integrated morpho-functional 
information. In these cases, continuation of the diagnostic 
workup or cytohistologic assessment was required. Con-
versely, when the available data were considered adequate, 
patients were referred for either treatment, follow-up, or best 
supportive care according to the MDT decision.
A time-trend analysis documented an increase in the abso-
lute number of cases presented to the MDT for radiologic 
consultation during the period under consideration (Tab. IV). 
Discussion
The results of this retrospective analysis show that HN im-
age review performed in a multidisciplinary context has a 
significant influence on clinical management as it gave rise 
to a modification of the initial radiologic report in one out of 
four cases, and led to a change in tumour treatment strategy 
in 11% of cases. Moreover, our work highlights the high 
quality of the image review provided, since the majority of 
the suggested modifications were confirmed by subsequent 
follow up and/or pathologic specimen examination. 
The importance of radiologists at the core of the MDT has 
been progressively advocated 3,5,15,16. Not only has the avail-
ability of radiologic imaging grown, but recent technologi-
cal advances in imaging acquisition and post-processing 
elaboration also require an increasing level of expertise. In 
the era of precision medicine, the definition of tumour vol-
ume and extent is of paramount importance to define the best 
treatment approach and to avoid geographically missing the 
target lesion (i.e. mini-invasive surgery, intensity-modulat-
ed and stereotactic body radiation therapy). Moreover, the 
availability of radiologic imaging with higher sensitivity and 
specificity during follow-up could result in selecting patients 
whose loco-regional recurrences are being diagnosed at an 
early stage, thus making them potentially good candidates 
for curative-intent salvage treatments (surgery and/or re-irra-
diation). Bergamini et al. 3 found that MDT evaluation led to 
staging refinement or modifications of the original treatment 
plan in approximately 60% of HNC cases; of those, 49% 
were indications to further diagnostic imaging, pathology as-
sessment and/or molecular analyses. Our results are in line 
with these observations. Accordingly, a recent systematic re-
view of 27 studies by Pillay et al. 6 has shown that the MDT 
discussion led to changes in former diagnostic reports in 4% 
to 45% of cases, with the significant limitation that only one 
of the included studies was dedicated to HNC. The results 
of our analysis are in line with those observations since ac-
curate review of the radiologic images led to a modification 
of tumour staging and/or treatment strategy in 13% and 11% 
of patients, respectively. 
Friedland et al. 7 reported that patients seen by the MDT 
were more likely to present with advanced stage disease 
compared to those evaluated by individual specialists. In-
terestingly, the investigators demonstrated a statistically 
significant benefit for stage IV patients discussed by the 
MDT, as they were more frequently eligible for multimo-
dality treatment and therefore could achieve better 5-year 
survival compared with non-MDT patients. This observa-
tion is confirmed by our series in which the majority of 
cases requiring a radiologic image review had advanced 
stage tumours (69% stage III and IV), corroborating that 
Figure 3. Schematic representation of MDT decision outline.
Table IV. Number of cases discussed with radiologic image revision compared to the total of patient discussed during the multidisciplinary team meetings, tem-
poral trend/year.
Considered period No. of patients 
discussed
Radiologic image revision 
(% of patients discussed)
April 2014 - March 2015 735 113 (15)
April 2015 - March 2016 804 195 (24)
April 2016 - March 2017 906 21 (23)
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the multidisciplinary approach is mostly required in cases 
for which a multimodality treatment strategy is mandatory. 
Since we did not have a comparative group of patients man-
aged by a single specialist, we were not able to quantify the 
impact of MDT management on patients’ outcome.
A previously published report by Loevner et al. analysed is-
sues similar to those analysed in the present paper for head 
and neck cancer patients. In this retrospective study, authors 
showed that in 56 of 136 cases (41%) the original reports 
were modified after re-evaluation by an expert radiologist 
with a significant impact on subsequent patient manage-
ment  17. Of note, the study involved patients treated in the 
2000s. Despite the significant technical advances in radio-
logic imaging in recent decades, the role of a dedicated radi-
ologist in a MDT has been strongly confirmed by the present 
study including a larger cohort, since a comparable propor-
tion of radiologic reports (48%) have been changed after the 
image review given by an expert head and neck radiologist. 
All these data highlight the importance of having an expert 
radiologist present during multidisciplinary discussions, 
suggesting that radiologic images of every patient should be 
reviewed in order to optimise the treatment strategy.
Conclusions
We are well aware of the limitations of our study, including: 
1) the retrospective nature of the analysis, 2) the exclusion 
of FDG-PET images from the radiologic revision in some 
patients, and 3) the unblinded evaluation of the initial ra-
diologic report. Moreover, each MDT discussion also took 
into account other findings such as clinical examination, 
symptoms and clinical history. The final MDT decision 
was, therefore, a multidimensional process in which the ra-
diologic images review represented only one, albeit funda-
mental, step. Nevertheless, we strongly believe our analysis 
may convey useful information not only towards the full 
integration of expert radiologists in the core of MDT for 
HNCs, but also towards a stronger standardisation of ra-
diologic imaging acquisition and reporting. Although ret-
rospective in nature, the strength of our work resides in the 
prospective collection of data related to all MDT decision. 
Moreover, as a tertiary care centre, follow-up information 
was available for the vast majority of cases, thus permitting 
the adequacy of the radiologic image review to be verified.
In conclusion, in one of four cases in our cohort radiology 
review led to modification of staging/treatment strategy. 
This finding strongly supports the importance of including 
a dedicated HN radiologist as a core member of the MDT. 
Further efforts of prospective nature are warranted in order 
to assess whether imaging review in the setting of MDTs 
translates into improved oncological outcomes.
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